AR039211A1 - Evaluacion del cancer colorectal - Google Patents

Evaluacion del cancer colorectal

Info

Publication number
AR039211A1
AR039211A1 ARP030101132A ARP030101132A AR039211A1 AR 039211 A1 AR039211 A1 AR 039211A1 AR P030101132 A ARP030101132 A AR P030101132A AR P030101132 A ARP030101132 A AR P030101132A AR 039211 A1 AR039211 A1 AR 039211A1
Authority
AR
Argentina
Prior art keywords
colorectal cancer
cancer assessment
cancer
assessment
portfolio
Prior art date
Application number
ARP030101132A
Other languages
English (en)
Spanish (es)
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of AR039211A1 publication Critical patent/AR039211A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ARP030101132A 2002-03-29 2003-04-01 Evaluacion del cancer colorectal AR039211A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36868702P 2002-03-29 2002-03-29

Publications (1)

Publication Number Publication Date
AR039211A1 true AR039211A1 (es) 2005-02-09

Family

ID=28675528

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101132A AR039211A1 (es) 2002-03-29 2003-04-01 Evaluacion del cancer colorectal

Country Status (10)

Country Link
US (1) US20030186303A1 (enExample)
EP (1) EP1355151A3 (enExample)
JP (2) JP4354725B2 (enExample)
KR (1) KR100984996B1 (enExample)
CN (2) CN101684500A (enExample)
AR (1) AR039211A1 (enExample)
AU (1) AU2003203561A1 (enExample)
BR (1) BR0303012A (enExample)
CA (1) CA2422305C (enExample)
MX (1) MXPA03002863A (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2475769C (en) * 2003-08-28 2018-12-11 Veridex, Llc Colorectal cancer prognostics
US20050153352A1 (en) * 2004-01-09 2005-07-14 Stanley Chang Cancer specific gene MG20
CA2610709A1 (en) * 2005-06-06 2006-12-14 Genentech, Inc. Transgenic models for different genes and their use for gene characterization
TW200730825A (en) * 2005-10-21 2007-08-16 Genenews Inc Method and apparatus for correlating levels of biomarker products with disease
CN101437962A (zh) * 2006-03-03 2009-05-20 维里德克斯有限责任公司 预测杜克氏b结肠癌复发的分子检测
CN102099485A (zh) * 2007-10-23 2011-06-15 临床基因组学有限公司 诊断新生物的方法-ⅱ
EP2169078A1 (en) 2008-09-26 2010-03-31 Fundacion Gaiker Methods and kits for the diagnosis and the staging of colorectal cancer
WO2013092960A1 (en) 2011-12-22 2013-06-27 Fundacion Gaiker Methods and kits for the diagnosis of colorectal cancer
CN102586420B (zh) * 2011-12-27 2014-10-22 盛司潼 一种检测乳腺癌易感基因的方法及试剂盒
CN102586423B (zh) * 2011-12-27 2015-01-07 盛司潼 一种检测结直肠癌易感基因的方法及试剂盒
CN115678994B (zh) * 2022-01-27 2025-01-21 上海爱谱蒂康生物科技有限公司 一种生物标志物组合、含其的试剂及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US635152A (en) * 1899-06-05 1899-10-17 Melancthon S Shotwell Car-body bolster.
US6275814B1 (en) * 1996-11-27 2001-08-14 Investment Strategies Network Investment portfolio selection system and method
US6003018A (en) * 1998-03-27 1999-12-14 Michaud Partners Llp Portfolio optimization by means of resampled efficient frontiers
US6350578B1 (en) * 1999-06-25 2002-02-26 The Regents Of The University Of California Method of quantitating dsDNA
US6175824B1 (en) * 1999-07-14 2001-01-16 Chi Research, Inc. Method and apparatus for choosing a stock portfolio, based on patent indicators

Also Published As

Publication number Publication date
AU2003203561A1 (en) 2003-10-23
CA2422305A1 (en) 2003-09-29
JP2003325191A (ja) 2003-11-18
BR0303012A (pt) 2004-09-08
KR20030078801A (ko) 2003-10-08
CN1502989A (zh) 2004-06-09
KR100984996B1 (ko) 2010-10-04
CA2422305C (en) 2013-07-30
EP1355151A3 (en) 2004-08-25
EP1355151A2 (en) 2003-10-22
CN101684500A (zh) 2010-03-31
JP4354725B2 (ja) 2009-10-28
JP2009153521A (ja) 2009-07-16
US20030186303A1 (en) 2003-10-02
MXPA03002863A (es) 2004-08-11

Similar Documents

Publication Publication Date Title
ES2570359T3 (es) Regiones ultraconservadas que codifican ARNnc
Brunner et al. Distant metastases from cutaneous squamous cell carcinoma—analysis of AJCC stage IV
Amit et al. Incidence of cervical lymph node metastasis and its association with outcomes in patients with adenoid cystic carcinoma. An international collaborative study
ECSP17025787A (es) Uso de paneles de genes mutantes de fgfr en la identificación de pacientes con cáncer que responderán al tratamiento con un inhibidor de fgfr
AR039211A1 (es) Evaluacion del cancer colorectal
MX2022002244A (es) Metodo para identificar respondedores a degradantes de smarca2/4.
ES2634546T3 (es) Uso de células madre mesenquimales modificadas genéticamente para expresar un gen suicida para tratar un cáncer
WO2006138275A3 (en) Compositions and methods for treating and diagnosing cancer
Magnano et al. Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population
CO5631459A2 (es) Metodos para la deteccion de desordenes geneticos
AR039617A1 (es) Evaluacion del cancer colorectal
GT200300061S (es) Maletin.
AR043808A1 (es) Pronostico de cancer colorrectal
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
TW200600785A (en) Method for diagnosing non-small cell lung cancer
MX2019000353A (es) Andamios de biomatriz para usarse en el diagnóstico y modelado del cáncer.
MX378733B (es) Métodos in vitro y composiciones para identificar y usarse en el tratamiento de lupus.
WO2008103971A3 (en) Prostate cancer survival and recurrence
McLean et al. Concurrent primary and metastatic cutaneous head and neck squamous cell carcinoma: analysis of prognostic factors
DE602004015626D1 (de) Bei brustkrebs
WO2007146668A3 (en) Use of imp3 as a prognostic marker for cancer
WO2005083429A8 (en) Breast cancer prognostics
CL2021000251A1 (es) Métodos de identificación de pacientes con posibilidad de beneficiarse de un tratamiento con un inhibidor de la telomerasa
BRPI0403290A (pt) Prognósticos para câncer de mama
ATE479898T1 (de) Reagenzien und verfahren zur verwendung bei der diagnose, klassifizierung und behandlung von krebs

Legal Events

Date Code Title Description
FC Refusal